PND27 ESTIMATING MARGINAL COST-EFFECTIVENESS USING A PERSON-LEVEL NET BENEFITS APPROACH WITH AN APPLICATION TO DISEASE-MODIFYING DRUGS IN MULTIPLE SCLEROSIS
MG Brown, C Skedgel, VA Hicks, IS Sketris, JD FiskVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65365-x
File:
PDF, 89 KB
english, 2007